Attention: You are using an outdated browser, device or you do not have the latest version of JavaScript downloaded and so this website may not work as expected. Please download the latest software or switch device to avoid further issues.

News > Research buzz > New proteomic technology accelerates COVID-19 biomarker and exploratory drug discovery

New proteomic technology accelerates COVID-19 biomarker and exploratory drug discovery

Researchers at the Crick have developed a new mass spectrometric acquisition technology, Scanning SWATH, that measures the human proteome faster and at a lower cost than its predecessors.
31 Mar 2021
United Kingdom | Germany
Research buzz

To view this News Article please log in or create a profile

Similar stories

Researchers from the Crick and UCL, working with Genomics England, have shown that rogue genetic material called extrach… More...

Researchers at the Francis Crick Institute and UCL have embarked on a study to establish a causal link between air pollu… More...

Mouse neuron grown on coverslips. The dots of colour are individual synapses. More...

Researchers at the Crick and UCL have developed a tool to analyse a key set of genes linked to the ability of cancer cel… More...

Have your say

 
image

Contact us

The Francis Crick Institute
1 Midland Road
London
NW1 1AT

connect@crick.ac.uk


This website is powered by
ToucanTech